InsureX

Opportunities:
The project has some strong team members and advisors, including the Chief Underwriter for General Re in Europe. Gen Re is one of the largest insurance companies in the world with $5.6 billion of premium in 2016. It is also a member of the Berkshire Hathaway group of companies. If Gen Re becomes one of the first companies to use InsureX’s platform, it can be a lot easier for other insurance companies to follow suit.
There is a genuine need for decentralized platform to improve efficiency of the entire process in the insurance industry. The insurance industry is currently manual, paper heavy, slow, and error-prone, which allows a lot of room for blockchain technology to disrupt the industry.
There is a network effect in play for this project – the bigger this platform is, the more attractive it is for other insurance companies to join the marketplace.
The project doesn’t really have a direct competitor now: Etherisc can be complementary to InsureX’s platform. ACORD’s partnership with R3 can be complementary to InsureX’s platform and InsureX has a strong connection to R3.
Lemonade is B2C vs. InsureX’s B2B focus.

Concerns:
The project is nothing but an idea now – there is no completed product to show for. Even if everything goes according to plan, they won’t begin signing up clients until Q4 2017. You need to trust that the team will be able to deliver.
The CEO of InsureX is also listed as the founder of another startup, Finserve. It is unclear how he will allocate his time between the two ventures.

Conclusion:
Overall, I like this ICO, both for short- and long-term potential. InsureX is tackling a big problem that needs to be fixed and if successful, token value can appreciate substantially.
Our thoughts of the tokens for short term and long term are as follows:
For short-term holding:
Good because the project has some strong team members and advisors, which should make it easy to attract funding to fill the hard cap quickly. Note that tokens will be distributed 3-4 weeks after the end of token sale, which is longer than the average ICO.
For long-term holding:
As mentioned above, the potential is great, but execution is key and it is unclear from what we see now.
If the team is able to deliver, I believe the InsureX platform can scale dramatically which is great for the long-term value of IXT. I see IXT as more of a high-risk-high-return type token.